malondialdehyde has been researched along with cloricromen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calapai, G; Campo, GM; Caputi, AP; Marciano, MC; Rizzo, A; Squadrito, F | 1 |
| Bevilaqua, C; Britti, D; Caputi, AP; Costantino, G; Cuzzocrea, S; De Sarro, A; Mazzon, E; Mazzullo, G | 1 |
2 other study(ies) available for malondialdehyde and cloricromen
| Article | Year |
|---|---|
Multiple actions of the coumarine derivative cloricromene and its protective effects on ischemic brain injury.
Topics: Animals; Body Temperature; Brain Chemistry; Brain Edema; Brain Ischemia; Chromonar; Gerbillinae; Lipid Peroxidation; Male; Malondialdehyde; Motor Activity; Nerve Degeneration; Peroxidase; Platelet Aggregation Inhibitors; Reperfusion Injury | 1995 |
Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.
Topics: Animals; Arthritis; Body Weight; Cattle; Chromonar; Collagen; Cyclooxygenase 2; Disease Progression; Enzyme Activation; Hindlimb; Interleukin-1; Isoenzymes; Male; Malondialdehyde; Nitric Oxide; Poly(ADP-ribose) Polymerases; Prostaglandin-Endoperoxide Synthases; Radiography; Rats; Rats, Inbred Lew; Severity of Illness Index; Time Factors; Tumor Necrosis Factor-alpha; Tyrosine | 2000 |